Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Kalhor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2006 - 2007
University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 2002 - 2006
Shahid Beheshti University of Medical SciencesClass of 1997
Certifications & Licensure
TX State Medical License 2008 - 2025
MI State Medical License 2006 - 2008
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors.Alissa J Cooper, Andrea Arfe, Biagio Ricciuti, Andréanne Gagné, Lynette M Sholl
JTO Clinical and Research Reports. 2025-01-01 - 3 citationsDelta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms.Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, Allison Stewart, Bingnan Zhang
NPJ Precision Oncology. 2024-11-19 - YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.C Allison Stewart, Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar
Clinical Cancer Research. 2024-10-15
Journal Articles
- Original Contribution Osteoclast-like Giant Cell Rich Carcinomas of the Lung: A Clinicopathological, Immunohistochemical, and Molecular Study of Three CasesNeda Kalhor, Cesar A Moran, ScienceDirect
- Thymomas with a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 CasesCesar A Moran, Neda Kalhor, American Journal of Clinical Pathology
- JAK1/STAT3 Activation Through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung CancerJohn D Minna, Jonathan M Kurie, J Jack Lee, Vassiliki A Papadimitrakopoulou, Neda Kalhor, Roy S Herbst, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
